Literature DB >> 32321754

Maternal T Cells in the Human Placental Villi Support an Allograft Response during Noninfectious Villitis.

Elizabeth Ann L Enninga1, Patrick Raber2, Reade A Quinton3, Rodrigo Ruano4, Nadia Ikumi5, Clive M Gray5, Erica L Johnson6, Rana Chakraborty4,7,8, Sarah E Kerr9.   

Abstract

During human pregnancy, proinflammatory responses in the placenta can cause severe fetal complications, including growth restriction, preterm birth, and stillbirth. Villitis of unknown etiology (VUE), an inflammatory condition characterized by the infiltration of maternal CD8+ T cells into the placenta, is hypothesized to be secondary to either a tissue rejection response to the haploidentical fetus or from an undiagnosed infection. In this study, we characterized the global TCR β-chain profile in human T cells isolated from placentae diagnosed with VUE compared with control and infectious villitis-placentae by immunoSEQ. Immunosequencing demonstrated that VUE is driven predominantly by maternal T cell infiltration, which is significantly different from controls and infectious cases; however, these T cell clones show very little overlap between subjects. Mapping TCR clones to common viral epitopes (CMV, EBV, and influenza A) demonstrated that Ag specificity in VUE was equal to controls and significantly lower than CMV-specific clones in infectious villitis. Our data indicate VUE represents an allograft response, not an undetected infection. These observations support the development of screening methods to predict those at risk for VUE and the use of specific immunomodulatory therapies during gestation to improve outcomes in affected fetuses.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32321754      PMCID: PMC7307888          DOI: 10.4049/jimmunol.1901297

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Comparison of C4d immunostaining methods in renal allograft biopsies.

Authors:  Megan L Troxell; Lauren A Weintraub; John P Higgins; Neeraja Kambham
Journal:  Clin J Am Soc Nephrol       Date:  2006-03-29       Impact factor: 8.237

2.  Using synthetic templates to design an unbiased multiplex PCR assay.

Authors:  Christopher S Carlson; Ryan O Emerson; Anna M Sherwood; Cindy Desmarais; Moon-Wook Chung; Joseph M Parsons; Michelle S Steen; Marissa A LaMadrid-Herrmannsfeldt; David W Williamson; Robert J Livingston; David Wu; Brent L Wood; Mark J Rieder; Harlan Robins
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 3.  Immunology of the maternal-fetal interface.

Authors:  Adrian Erlebacher
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

4.  Placental villitis of unknown origin: epidemiologic associations.

Authors:  David M Becroft; John M Thompson; Edwin A Mitchell
Journal:  Am J Obstet Gynecol       Date:  2005-01       Impact factor: 8.661

Review 5.  Maternal acceptance of the fetus: true human tolerance.

Authors:  Indira Guleria; Mohamed H Sayegh
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

6.  Human decidual leukocytes from early pregnancy contain high numbers of gamma delta+ cells and show selective down-regulation of alloreactivity.

Authors:  L Mincheva-Nilsson; S Hammarström; M L Hammarström
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

7.  Placental pathologic findings in preterm birth.

Authors:  C M Salafia; C A Vogel; A M Vintzileos; K F Bantham; J Pezzullo; L Silberman
Journal:  Am J Obstet Gynecol       Date:  1991-10       Impact factor: 8.661

Review 8.  The immunological basis of villitis of unknown etiology - review.

Authors:  J A Tamblyn; D M Lissauer; R Powell; P Cox; M D Kilby
Journal:  Placenta       Date:  2013-07-26       Impact factor: 3.481

9.  Placental villitis of unclear etiology during ovum donor in vitro fertilization pregnancy.

Authors:  Aaron K Styer; Hannah J Parker; Drucilla J Roberts; Darryl Palmer-Toy; Thomas L Toth; Jeffrey L Ecker
Journal:  Am J Obstet Gynecol       Date:  2003-10       Impact factor: 8.661

10.  Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood Transplantation.

Authors:  Athina Soragia Gkazi; Ben K Margetts; Teresa Attenborough; Lana Mhaldien; Joseph F Standing; Theres Oakes; James M Heather; John Booth; Marlene Pasquet; Robert Chiesa; Paul Veys; Nigel Klein; Benny Chain; Robin Callard; Stuart P Adams
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

View more
  5 in total

1.  Immune landscape of human placental villi using single-cell analysis.

Authors:  Jessica M Toothaker; Oluwabunmi Olaloye; Blake T McCourt; Collin C McCourt; Tatiana N Silva; Rebecca M Case; Peng Liu; Dean Yimlamai; George Tseng; Liza Konnikova
Journal:  Development       Date:  2022-02-17       Impact factor: 6.868

2.  T-Cell Homeostatic Imbalance in Placentas From Women With Human Immunodeficiency Virus in the Absence of Vertical Transmission.

Authors:  Nadia M Ikumi; Komala Pillay; Tamara Tilburgs; Thokozile R Malaba; Sonwabile Dzanibe; Elizabeth Ann L Enninga; Rana Chakraborty; Mohammed Lamorde; Landon Myer; Saye Khoo; Heather B Jaspan; Clive M Gray
Journal:  J Infect Dis       Date:  2021-12-08       Impact factor: 7.759

Review 3.  Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.

Authors:  Emily F Cornish; Thomas McDonnell; David J Williams
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

4.  Expression of Immune Checkpoint Receptors in Placentae With Infectious and Non-Infectious Chronic Villitis.

Authors:  Maryam Shahi; Ricardo Mamber Czeresnia; E Heidi Cheek; Reade A Quinton; Rana Chakraborty; Elizabeth Ann L Enninga
Journal:  Front Immunol       Date:  2021-07-30       Impact factor: 7.561

5.  Type 1 Cytotoxic T Cells Increase in Placenta after Intrauterine Inflammation.

Authors:  Jin Liu; Yang Liu; Snigdha Panda; Anguo Liu; Jun Lei; Irina Burd
Journal:  Front Immunol       Date:  2021-09-08       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.